Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Quince Therapeutics, Inc. | 365,000 | reported | 23 Jan 2026 | tx 24+2,206,719−448,612 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2026 | GRANT_AWARD | Quince Therapeutics, Inc. | 365,000 | 0.00 USD | deriv |
| 05 Dec 2025 | EXERCISE | Quince Therapeutics, Inc. | 25,280 | 0.94 USD | |
| 05 Dec 2025 | EXERCISE | Quince Therapeutics, Inc. | 2,271 | 0.55 USD | |
| 05 Dec 2025 | EXERCISE | Quince Therapeutics, Inc. | 25,280 | 0.00 USD | deriv |
| 05 Dec 2025 | EXERCISE | Quince Therapeutics, Inc. | 2,271 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 37,736 | 1.20 USD | |
| 18 Jun 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 37,736 | 0.13 USD | deriv |
| 28 Jan 2025 | GRANT_AWARD | Quince Therapeutics, Inc. | 450,000 | 0.00 USD | deriv |
| 19 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 2,155 | 0.58 USD | first after silence |
| 20 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 2,500 | 0.61 USD | |
| 21 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 23,565 | 0.63 USD | |
| 21 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 2,280 | 0.61 USD | |
| 21 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 5,000 | 0.62 USD | |
| 20 Aug 2024 | PURCHASE | Quince Therapeutics, Inc. | 3,424 | 0.60 USD | |
| 04 Jun 2024 | EXERCISE | Quince Therapeutics, Inc. | 56,061 | 0.55 USD | |
| 04 Jun 2024 | EXERCISE | Quince Therapeutics, Inc. | 56,061 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Quince Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 24 Oct 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 08 Aug 2023 | PURCHASE | Quince Therapeutics, Inc. | 71,762 | 1.22 USD | |
| 01 Feb 2023 | GRANT_AWARD | Quince Therapeutics, Inc. | 225,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 16,224 | — | |
| 19 May 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 103,500 | — | deriv |
| 23 May 2022 | GRANT_AWARD | Quince Therapeutics, Inc. | 353,656 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 Aug 2024.